EW
Edwards Lifesciences CorporationEdwards Lifesciences Corporation operates in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry.
The numbers · FY2025, filed
SEC EDGARAll filed figures
Snapshot
SEC EDGAR · FY 2025-12-31Revenue by fiscal year
Operating leverage — margins
Financials, annual · income and cash flowSEC EDGAR · open ▸
Financials — annual
SEC EDGAR · last 5 FY · tap a row to explain it| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $5.2B | $4.5B | $5.0B | $5.4B | $6.1B |
| Gross Profit | $4.0B | $3.7B | $4.0B | $4.3B | $4.7B |
| Operating Income | $1.7B | $1.5B | $1.3B | $1.4B | $1.3B |
| Net Income | $1.5B | $1.5B | $1.4B | $4.2B | $1.1B |
| Diluted EPS | $2.38 | $2.44 | $2.30 | $6.97 | $1.83 |
| Operating Cash Flow | $1.7B | $1.2B | $895.8M | $542.3M | $1.6B |
| Free Cash Flow | $1.4B | $973.6M | $642.8M | $289.9M | $1.3B |
Same industry
In the screener →Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.